Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-055907
Filing Date
2021-11-10
Accepted
2021-11-10 06:37:05
Documents
62
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sybx-10q_20210930.htm   iXBRL 10-Q 2486373
2 EX-31.1 sybx-ex311_9.htm EX-31.1 16800
3 EX-31.2 sybx-ex312_8.htm EX-31.2 16739
4 EX-32.1 sybx-ex321_7.htm EX-32.1 6989
5 EX-32.2 sybx-ex322_6.htm EX-32.2 6970
  Complete submission text file 0001564590-21-055907.txt   7599010

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sybx-20210930.xsd EX-101.SCH 42893
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sybx-20210930_cal.xml EX-101.CAL 41733
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sybx-20210930_def.xml EX-101.DEF 150785
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sybx-20210930_lab.xml EX-101.LAB 349905
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sybx-20210930_pre.xml EX-101.PRE 268228
11 EXTRACTED XBRL INSTANCE DOCUMENT sybx-10q_20210930_htm.xml XML 1330927
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 211394301
SIC: 2834 Pharmaceutical Preparations